Navigation Links
New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
Date:11/9/2010

CZP treatment group achieved ACR20 response versus the control group (25.9%).  Additional efficacy evaluated in the trial included ACR50/70 response rates, as well as the DAS28[CRP] disease activity score and the Health Assessment Questionnaire-Disability Index (HAQ-DI) measuring physical function.

Clinical responses among patients in the CZP treatment group were rapid. ACR 20/50 responses were significantly superior to control (31.8% vs 8.5% and 9.6% vs 1.4%, p<0.001 for both) from the first time point (week 2) onwards. Significant improvements in DAS28[CRP] were reported among patients treated with CZP vs. the placebo group.  In addition, CZP patients reported rapid and significant improvements in HAQ-DI vs. placebo at the first time point measured (week 2).

Similar ACR20 responses were seen across the various patient populations regardless of baseline disease duration or activity; baseline use of methotrexate; or prior use of TNF- inhibitors.  ACR50 and ACR70 responses at week 12 were 26.6% and 13% for patients treated with CZP compared to the placebo group (9.9% and 2.8% respectively).

Treatment with CZP was generally well tolerated. Adverse and serious adverse event rates were comparable between CZP and placebo treatment groups with no new safety signals observed through week 12.  The most common serious infections were lower respiratory tract and lung infections.   The most common adverse events were infections and infestations, musculoskeletal and connective tissue disorders, and nervous system disorders.

For full study information, please see:  http://www.abstracts2view.com/acr/titleindex.php?num=E&page=2 For further informationBert Kelly, Communication and Public Relations Manager, UCB404.784.6303, Bert.Kelly@ucb.comSarah Fox, Co
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
2. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
3. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
4. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
5. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
6. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
7. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
8. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
9. Marken Rapidly Responds to Global Supply Chain Security Measures
10. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
11. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... , September 12, 2014 ... Market by Application [Beverages (Alcoholic, CSD, Sports & Energy ... Pet Food, Meat & Seafood)], by Material (Aluminum ... by MarketsandMarkets, defines and segments the Food & ... of each application in terms of volumes and ...
(Date:9/12/2014)... , Sept. 12, 2014 /PRNewswire-iReach/ -- 9 th ... 22-24, 2014 – Bethesda, MD ... http://www.fdanews.com/9thInspectionsSummitEarlyBird   Photo - http://photos.prnewswire.com/prnh/20140912/145652 ... for the next inspection than to get a glimpse ... during and after an inspection. Come to ...
(Date:9/12/2014)... 12, 2014 Research and Markets ... "Global Medical Technologies Market 2014-2018" report to ... a collective term for software solutions, medical devices, ... health. The Global Medical Technologies market covers active ... In vitro diagnostics technology, dental technology, electromechanical medical ...
Breaking Medicine Technology:Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 2Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 4FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 2FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 3Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 3
... and CAMPBELL, Calif. , May ... sophisticated risk characterization and personalized therapy guidelines for ... of advanced tests, offering an accompanying nutrition program, ... Director stated:  "With appropriate risk characterization and treatment, ...
... May 25 The U.S. Food and Drug Administration approved Lumizyme (alglucosidase ... a rare genetic disorder. , , ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , , , ... an estimated 1 in every 40,000 to 300,000 births. Its primary symptom is ...
Cached Medicine Technology:Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program. 2FDA Approves New Treatment for Late-Onset Pompe Disease 2FDA Approves New Treatment for Late-Onset Pompe Disease 3
(Date:9/15/2014)... (PRWEB) September 15, 2014 These events ... business requirements are in each state; and how to ... include industry professionals, such as medical marijuana pioneer ... and cannabis business consultant Travis Howard of Shift ... running legal marijuana businesses all over the United States. ...
(Date:9/15/2014)... 15, 2014 Concox , a ... wireless communications equipment, is dedicated to bringing reliable products ... Being the best-seller in Concox’s products, GT06N not only ... customers. GT06N is a mini and original GPS car ... be installed in the shelters on cars or trucks. ...
(Date:9/14/2014)... 14, 2014 Adults who are planning ... Quotes Pros website to find quotes for life insurance ... year at http://quotespros.com/life-insurance.html is now delivering the ... partners that are preparing the rates information for adults ... most U.S. states. As a way to simplify the ...
(Date:9/14/2014)... September 14, 2014 Proper oral care ... from Butte, Mont., found a way to teach children ... patent-pending B LITE toothbrush encourages an effective brushing habit ... full two minutes without overbrushing, eliminating guesswork and promoting ... easy to use, suitable for all children, and producible ...
(Date:9/14/2014)... SUNDAY, Sept. 14, 2014 (HealthDay News) -- Getting enough sleep each ... work due to illness, a new study suggests. The study ... who were followed for an average of seven years. Those ... a night were much more likely to have extended absences from ... risk for taking time off from work due to sickness were ...
Breaking Medicine News(10 mins):Health News:How to Start And Run a Successful Legal Marijuana Business 2Health News:iConcox GPS Vehicle Tracker GT06N Designed for Customers' Security 2Health News:Quotes for Life Insurance Now Offered at New Consumer Portal Online 2Health News:A Good Night's Sleep May Mean a Good Day's Work 2
... Kozhikode have claimed that homeopathy offers a cure for ... several medicines like Uppttorium, Rextokes and Brayonia could effectively ... in the hospital that the Andhra Pradesh Government ... Tamil Nadu and Karnataka were also contemplating similar measures, ...
... is an integral part of health, and assessment of sleep ... to an editorial in the September 18 issue of Archives ... The issue is devoted to studies of sleep and health. ... that sleep serves as an indicator of health and quality ...
... of Similac Infant Formula were off the shelf, after its ... a suspected flaw in the bottle. No repercussions after the ... company has decided to recall the product in order to ... content in the bottle. ,Given below ...
... will soon ban gifts like coffee mugs, notepads, pens ... the Stanford University Medical Center offices.// ,The rules, expected ... physicians and medical students at Stanford University to accept ... representative selling drugs, medical devices or related products. ...
... from the rich countries to achieve the universal goal of ... ,Five times more money is needed to meet the goal ... papers published online by the Lancet today. It coincides with ... Norwegian government. , ,According to Timothy Powell-Jackson and ...
... than 1.6 million U.S. adults are estimated to use ... sleeping, according to the results of a// national survey ... Internal Medicine, a theme issue on sleep. ... difficulty sleeping, also known as insomnia, according to background ...
Cached Medicine News:Health News:Incorporate Sleep Evaluation into Routine Medical Care 2Health News:Pharmaceutical Companies Banned from Giving Gifts at Stanford 2Health News:Pharmaceutical Companies Banned from Giving Gifts at Stanford 3Health News:Pharmaceutical Companies Banned from Giving Gifts at Stanford 4Health News:Child death reduction needs five times more funds 2Health News:About 5 Percent of Adults with Insomnia Use Alternative Therapies 2
... PoliPhase® is a biologically based ... two component system consisting of a ... the control of internal bleeding. ... readily flow on to a prepared ...
The DuraSeal System includes an innovative polyethylene glycol hydrogel sealant and applicator packaged in a single-use kit which can be stored at room temperature for convenience and quick preparati...
... DERMABOND* Topical Skin Adhesive gives you ... adhesive is intended for topical application only ... of wounds from surgical incisions, including punctures ... cleansed, trauma-induced lacerations. DERMABOND adhesive may be ...
... BD Cell-Tak™ Cell and Tissue Adhesive is ... Mytilus edulis (marine mussel). These proteins are ... by the mussel to anchor itself to ... Cell-Tak Cell and Tissue Adhesive is used ...
Medicine Products: